These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 992713)

  • 1. Lymphocyte nucleolar activation as a marker of autoimmune disorders. II. Observations in patients with systemic lupus erythematosus and other connective tissue diseases.
    Korcákova L; Pekárek J; Rovenský J; Trnavský K; Lukác J; Haskova V
    Immunology; 1976 Nov; 31(5):803-5. PubMed ID: 992713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Connective tissue diseases with immune disorders (collagen diseases)].
    Strukov AI; Simakova RA; Kop'eva TN; Kakturskiĭ LV
    Arkh Patol; 1970; 32(7):20-35. PubMed ID: 4100744
    [No Abstract]   [Full Text] [Related]  

  • 3. CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Smith HR; Olson RR
    J Rheumatol; 1990 Jun; 17(6):833-5. PubMed ID: 1696993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lymphocyte nucleoli in the peripheral blood and knee joint effusions in patients with rheumatoid arthritis].
    Stĕpán J; Smetana K; Smolíková M; Likovský Z; Havelka S
    Z Rheumatol; 1978; 37(1-2):40-4. PubMed ID: 629094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The area of lymphocyte nucleoli, a new method estimating the blastic transformation of stimulated lymphocytes in in vitro cultures.
    Micu D; Guran M; Olinescu V; Constantineanu I
    Med Interne; 1981; 19(4):397-404. PubMed ID: 7336100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoallergic diseases. II].
    Feo F
    Minerva Med; 1978 Oct; 69(51):3546-9. PubMed ID: 83553
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibodies to extractable nuclear antigens in rheumatic diseases].
    Ivanova SM; Ivanova MM; Speranskiĭ AI
    Ter Arkh; 1980; 52(6):59-62. PubMed ID: 7404390
    [No Abstract]   [Full Text] [Related]  

  • 8. [Characterization of subpopulations of circulating lymphocytes in patients with various connective tissue diseases (author's transl)].
    Abud-Mendoza C; Ruíz-Argüelles A; Díaz-Jouanen E; Alarcón-Segovia D
    Rev Invest Clin; 1979; 31(1):11-9. PubMed ID: 312520
    [No Abstract]   [Full Text] [Related]  

  • 9. The area of lymphocyte nucleoli (ALN) and its relationship with RNA synthesis in lymphocytes after blastic transformation in in vitro cultures.
    Micu D; Vilău C; Mihăilescu E; Guran M; Olinescu V; Constantineanu I
    Med Interne; 1982; 20(3):239-42. PubMed ID: 6186003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of connective tissue disease.
    Holborow EJ
    Trans Ophthalmol Soc U K (1962); 1974 Sep; 94(3):712-20. PubMed ID: 4282889
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases].
    Velasco M; Losada M; Losada A; Ramirez G
    Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546
    [No Abstract]   [Full Text] [Related]  

  • 12. [Autoantibodies in infantile pathology: immunofluoromorphological studies in sections of cardiac and skeletal muscular tissue].
    Vaccaro R; Rossoni R; Alestra P
    Minerva Pediatr; 1968 Oct; 20(42):2187-90. PubMed ID: 4915690
    [No Abstract]   [Full Text] [Related]  

  • 13. [Detection of antinuclear factors in rheumatic diseases].
    Ménard HA; Myhal D; Camerlain M; Lussier A
    Union Med Can; 1974 Apr; 103(4):722-6. PubMed ID: 4601283
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocytes' cytotoxicity towards cells of human lymphoblastoid lines in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Skurkovich SV; Skorikova AS; Dubrovina NA; Riabova TV; Eremkina EI; Golodnenkova VN; Klinova EG; Olshanski AJ; Shurlapova NF
    Ann Allergy; 1977 Nov; 39(5):344-50. PubMed ID: 921001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional analysis of immune complex-rich serum fractions in autoimmune diseases by in vitro C3 activation of fresh blood].
    Böhm U; Merétey K; Falus A; Bozsóky S
    Z Rheumatol; 1981; 40(3):126-30. PubMed ID: 6456623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The lymphocytotoxins].
    Verroust P
    Presse Med (1893); 1971 Jul; 79(33):1485. PubMed ID: 5565230
    [No Abstract]   [Full Text] [Related]  

  • 17. Value of the lymphocyte nucleolar parameters for the estimation of therapy effectiveness in chronic diseases with immune lymphocyte involvement.
    Micu D; Mihăilescu E; Sighetea E; Olinescu V; Constantineanu I
    Med Interne; 1979; 17(3):285-91. PubMed ID: 583079
    [No Abstract]   [Full Text] [Related]  

  • 18. IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases.
    Cook AD; Mackay IR; Cicuttini FM; Rowley MJ
    J Rheumatol; 1997 Nov; 24(11):2090-6. PubMed ID: 9375865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Collagen diseases within the framework of autoimmune diseases].
    Fanconi G
    Munch Med Wochenschr; 1966 Mar; 108(12):633-40. PubMed ID: 4383334
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical significance of tubuloreticular structures in circulating lymphocytes of patients with erythematodes].
    Horváth A; Schaff Z; Kramer M; Szepesházi K; Ablonczy E; Bognár A; Király K; Lapis K
    Orv Hetil; 1977 Feb; 118(9):500-3. PubMed ID: 840483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.